Hookipa Pharma Stock Price Prediction
| HOOK Stock | USD 2.29 0.14 6.51% |
Oversold Vs Overbought
39
Oversold | Overbought |
EPS Estimate Next Quarter (1.60) | EPS Estimate Current Year (2.44) | EPS Estimate Next Year (4.80) | Wall Street Target Price 38.75 | EPS Estimate Current Quarter (1.90) |
Using Hookipa Pharma hype-based prediction, you can estimate the value of Hookipa Pharma from the perspective of Hookipa Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Hookipa Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Hookipa because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Hookipa Pharma after-hype prediction price | USD 2.4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Hookipa |
Hookipa Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Hookipa Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Hookipa Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Hookipa Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Hookipa Pharma Estimiated After-Hype Price Volatility
In the context of predicting Hookipa Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Hookipa Pharma's historical news coverage. Hookipa Pharma's after-hype downside and upside margins for the prediction period are 0.12 and 6.15, respectively. We have considered Hookipa Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Hookipa Pharma is risky at this time. Analysis and calculation of next after-hype price of Hookipa Pharma is based on 3 months time horizon.
Hookipa Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Hookipa Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hookipa Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Hookipa Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.21 | 3.75 | 0.11 | 0.05 | 7 Events / Month | 8 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.29 | 2.40 | 4.80 |
|
Hookipa Pharma Hype Timeline
Hookipa Pharma is currently traded for 2.29. The entity has historical hype elasticity of 0.11, and average elasticity to hype of competition of 0.05. Hookipa is estimated to increase in value after the next headline, with the price projected to jump to 2.4 or above. The average volatility of media hype impact on the company the price is over 100%. The price upswing on the next news is projected to be 4.8%, whereas the daily expected return is currently at -1.21%. The volatility of related hype on Hookipa Pharma is about 8653.85%, with the expected price after the next announcement by competition of 2.34. Hookipa Pharma currently holds about 117.92 M in cash with (57.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.16. Given the investment horizon of 90 days the next estimated press release will be in about 7 days. Check out Hookipa Pharma Basic Forecasting Models to cross-verify your projections.Hookipa Pharma Related Hype Analysis
Having access to credible news sources related to Hookipa Pharma's direct competition is more important than ever and may enhance your ability to predict Hookipa Pharma's future price movements. Getting to know how Hookipa Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Hookipa Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MREO | Mereo BioPharma Group | (0.15) | 9 per month | 0.00 | (0.10) | 5.14 | (5.79) | 19.32 | |
| TERN | Terns Pharmaceuticals | 0.30 | 8 per month | 0.00 | (0.09) | 5.68 | (5.96) | 34.09 | |
| PDSB | PDS Biotechnology Corp | (0.07) | 9 per month | 0.00 | (0.15) | 7.67 | (6.76) | 31.83 | |
| INZY | Inozyme Pharma | (0.03) | 8 per month | 0.00 | (0.27) | 5.68 | (7.92) | 16.62 | |
| DAWN | Day One Biopharmaceuticals | 0.23 | 9 per month | 2.72 | (0.04) | 3.84 | (3.69) | 11.44 | |
| ELDN | Eledon Pharmaceuticals | 0.17 | 5 per month | 3.04 | 0.09 | 10.09 | (4.24) | 28.12 | |
| XFOR | X4 Pharmaceuticals | 0.02 | 7 per month | 0.00 | (0.08) | 6.90 | (10.61) | 62.35 | |
| ABOS | Acumen Pharmaceuticals | (0.10) | 4 per month | 0.00 | (0.06) | 7.52 | (6.67) | 28.07 | |
| AMLX | Amylyx Pharmaceuticals | 0.02 | 11 per month | 4.02 | 0.24 | 10.06 | (6.13) | 33.56 |
Hookipa Pharma Additional Predictive Modules
Most predictive techniques to examine Hookipa price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Hookipa using various technical indicators. When you analyze Hookipa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Hookipa Pharma Predictive Indicators
The successful prediction of Hookipa Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Hookipa Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Hookipa Pharma based on analysis of Hookipa Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Hookipa Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Hookipa Pharma's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 3.69 | 4.13 | 3.5 | 3.33 | Net Debt To EBITDA | 0.8 | 1.77 | 1.43 | 2.71 |
Story Coverage note for Hookipa Pharma
The number of cover stories for Hookipa Pharma depends on current market conditions and Hookipa Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Hookipa Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Hookipa Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Hookipa Pharma Short Properties
Hookipa Pharma's future price predictability will typically decrease when Hookipa Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Hookipa Pharma often depends not only on the future outlook of the potential Hookipa Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hookipa Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.5 M | |
| Cash And Short Term Investments | 117.1 M |
Check out Hookipa Pharma Basic Forecasting Models to cross-verify your projections. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.67) | Revenue Per Share 4.403 | Quarterly Revenue Growth (0.52) | Return On Assets (0.20) | Return On Equity (0.49) |
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.